Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]	1595	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	1434	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	1467	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	1691	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	1759	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	2349	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	2352	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	2427	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	2484	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	2538	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	2608	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	2693	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	2713	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	2805	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	2811	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	2892	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	2982	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	2990	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	3159	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	3212	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	3258	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	3306	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	3358	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	3484	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	3499	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	3583	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	3608	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	3674	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	3782	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	3874	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	3897	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	3915	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	3980	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	4133	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	4309	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	4360	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	4468	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	4785	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	4806	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	4936	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	5380	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	5407	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	5630	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	5661	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	6074	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	6398	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	6412	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	6577	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	6603	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	6611	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	8336	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	8526	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	8749	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	9351	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	9415	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	9863	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	9920	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	9980	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	10169	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	10624	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	10729	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	10785	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	11025	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	11029	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	12390	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	12670	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	12824	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	12836	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	13046	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	15763	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	17586	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	18551	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	21236	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	22322	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	23206	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	29155	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-	85965	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BETA-MALTOSE (CAS# 69-79-4); (M+CL)-		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	1434	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	1467	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	1691	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	1759	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	2352	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	2433	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	2484	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	2538	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	2608	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	2693	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	2713	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	2805	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	2811	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	2817	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	2892	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	2990	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	3159	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	3258	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	3267	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	3358	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	3458	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	3484	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	3499	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	3608	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	3674	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	3782	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	3854	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	3874	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	3897	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	3915	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	3980	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	4133	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	4135	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	4309	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	4360	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	4468	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	4806	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	4936	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	5380	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	5407	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	5630	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	5661	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	6074	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	6398	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	6412	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	6577	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	6603	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	6611	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	8336	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	8526	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	8749	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	9351	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	9415	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	9863	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	9920	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	MALTOSE (CAS# 69-79-4); (M+CL)-	10169	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y

Return to search page